Small Molecules

05 Jan 2007 Sound Pharmaceuticals Announces the Successful Completion of its Phase I Clinical Trial for SPI-1005
05 Jan 2007 BiPar Sciences Begins Enrollment in Phase 1b Study of BSI-201
05 Jan 2007 Neosil Announces Positive Phase 2 Data for NEOSH101, an Investigational Treatment for Androgenetic Alopecia
05 Jan 2007 Enzon Pharmaceuticals Files Investigational New Drug Application for Novel HIF-1alpha Antagonist in Cancer
05 Jan 2007 BioMarin Initiates Phase 2 Clinical Study of 6R-BH4 in Peripheral Arterial Disease
04 Jan 2007 Cytokinetics and Amgen Announce Strategic Alliance in Heart Failure
04 Jan 2007 D-Pharm announces positive Phase IIb trial results for DP-b99 in acute stroke patients
04 Jan 2007 Theravance Initiates Phase 2 Clinical Program with Investigational Heterodimer Antibiotic
04 Jan 2007 Catalyst Pharmaceutical Partners Provides an Update on Its Clinical Development Plans for CPP-109
04 Jan 2007 Aerovance Announces Positive Top-Line Results from Phase 2a Trial of Inhaled AEROVANT(TM) in Asthma Patients
04 Jan 2007 DURECT Starts Phase II Dosing for TRANSDUR(TM)-Bupivacaine (DUR-843)
04 Jan 2007 Poniard Pharmaceuticals Receives Special Protocol Assessment for Pivotal Phase 3 Trial of Picoplatin for Small Cell Lung Cancer
04 Jan 2007 Genaera Corporation Terminates Evizon(TM) Clinical Program And Restructures
03 Jan 2007 Exelixis Signs Co-Development Agreement With Genentech for Small Molecule Oncology Compound
03 Jan 2007 Phase II clinical trial of Biomira's PX-12 in patients with advanced pancreatic cancer now open for patient enrollment
03 Jan 2007 Daiichi Sankyo, Inc. Announces Filing Of Supplemental New Drug Application For WelChol In The Treatment Of Type 2 Diabetes Mellitus

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top